Penn Medicine UPenn HFpEF Symposium 2023

Description Include: 39 videos 35 pdfs, size: 15.3 GB Target Audience: cardiologist, pulmonologist, radiologist, endocrinologist, sleep medicine physician Sample video: contact me for sample video Information: Date & Location Friday, March 24, 2023, 8:00 AM – Saturday, March 25, 2023, 7:20 PM, Smilow Center and Online, Philadelphia, PA Course Overview While the incidence of heart failure with reduced ejection fraction (HFrEF) has decreased, that of heart failure with preserved ejection fraction (HFpEF) continues to rise, accounting for ~50% of heart failure hospitalizations. Patients with HFpEF suffer mentally and physically, similar to their HFrEF counterparts, and are markedly limited in terms of their functional capacity and quality of life. Yet in contrast to HFrEF, there are few effective pharmacologic treatments for HFpEF, despite numerous clinical trials. To address this urgent need, many clinicians and researchers have focused on this important medical and societal issue. Improved strategies now exist to diagnose this condition, and multifaceted treatment options can help to alleviate some of the morbidity of the disease. This symposium will highlight diagnostic strategies and review the evidence base for pharmacologic therapies. Treatment of comorbid conditions found in HFpEF patients will also be discussed. Additional didactics highlighting the sources of exertional intolerance in HFpEF patients will be presented, with an emphasis on cardiopulmonary exercise testing. The topics chosen for this conference represent the state-of-the-art in HFpEF management, incorporating the expertise of numerous disciplines including cardiology, pulmonology, radiology, sleep medicine, and endocrinology. The meeting is intended to provide an in-depth summary of HFpEF management to practicing clinicians across numerous disciplines, including Physicians, Nurse Practitioners, and Physician Assistants. Target Audience Specialties – FAMILY MEDICINE, INTERNAL MEDICINE, INTERNAL MEDICINE – Advanced Heart Failure and Transplant Cardiology Learning Objectives After completing this activity, participants should be able to: Review the diagnostic criteria for HFpEF, including when to use advanced imaging or hemodynamic assessment Discuss HFpEF mimickers, including amyloidosis, sarcoidosis, and inherited cardiomyopathies Discuss the role of non-cardiac structures (such as the arterial system and other organs) in the pathogenesis and treatment of HFpEF Describe the electrophysiologic manifestations of HFpEF and their treatments Discuss novel therapies that are on the horizon for HFpEF Review the potential causes of exertional intolerance in HFpEF patients.   Topics: Acute nitroglycerin use worsens ventilatory efficiency during exercise in patients with heart failure with preserved ejection fraction.mp4 Addressing Disparities in the Management of HFpEF and its Comorbidities.mp4 Addressing Disparities in the Management of HFpEF and its Comorbidities.pdf Advanced Echo Techniques to Diagnose HFpEF.mp4 Advanced Echo Techniques to Diagnose HFpEF.pdf Advanced Imaging – PET and cMRI in HFpEF.mp4 Advanced Imaging – PET and cMRI in HFpEF.pdf Atrial Fibrillation in HFpEF – Should We Ablate Sooner..mp4 Atrial Fibrillation in HFpEF – Should We Ablate Sooner..pdf Case Presentation – Cardiology Fellows Junior Faculty 2.mp4 Case Presentation – Cardiology Fellows Junior Faculty 2.pdf Case Presentation – Cardiology Fellows Junior Faculty.mp4 Case Presentation – Cardiology Fellows Junior Faculty.pdf Case Presentation- HF Cardiology Fellow 2.mp4 Case Presentation- HF Cardiology Fellow 2.pdf Case Presentation- HF Cardiology Fellow.mp4 Case Presentation- HF Cardiology Fellow.pdf Chronotropic Incompetence- Modulating Sinus Rhythm and Pacing.mp4 Chronotropic Incompetence- Modulating Sinus Rhythm and Pacing.pdf Clinical Factors and Biomarkers – Scoring Systems (e.g. H2FPEF).mp4 Clinical Factors and Biomarkers – Scoring Systems (e.g. H2FPEF).pdf Debate- It’s the Heart! High Pressures ‘Limit’ Exercise in HFpEF.mp4 Debate- It’s the Heart! High Pressures ‘Limit’ Exercise in HFpEF.pdf Debate- The Heart Isn’t Normal but It’s Not Everything – Peripheral Limitations in HFpEF.pdf Development of novel mouse models recapitulating Heart Failure with preserved Ejection Fraction.mp4 Diuretics and Overcoming Resistance.mp4 Diuretics and Overcoming Resistance.pdf Drugs to Modulate Contractility – Levosimendan and Mavacamten.mp4 Drugs to Modulate Contractility – Levosimendan and Mavacamten.pdf EpiProteomic Profiling Of Human Heart Biopsies Reveals Histone H3k27acMediated Metabolic Dysfunction In Heart Failure With Preserved Ejection Fraction.mp4 Exercise Physiology, as seen Through a CPET Test.mp4 Exercise Physiology, as seen Through a CPET Test.pdf Fibrosis In HFpEF – What it Means and What to do About it. The New and the Old.mp4 Fibrosis In HFpEF – What it Means and What to do About it. The New and the Old.pdf HFpEF Epidemiology – a Growing Problem.mp4 HFpEF Epidemiology – a Growing Problem.pdf HFpEF – A Global Perspective.mp4 HFpEF – A Global Perspective.pdf HFpEF23_Brochure_v24.pdf Implantable PA Monitors in HFpEF.mp4 Implantable PA Monitors in HFpEF.pdf Intracardiac Shunt Devices.mp4 Intracardiac Shunt Devices.pdf Keynote- HFpEF Guidelines – Phenogroups to Guide Therapies.mp4 Keynote- HFpEF Guidelines – Phenogroups to Guide Therapies.pdf Keynote- Redefining the Pathobiology of HFpEF.mp4 Keynote- Redefining the Pathobiology of HFpEF.pdf Keynote- The Future of HFpEF Treatment.pdf Lung Disease and Pulmonary Hypertension in HFpEF.mp4 Lung Disease and Pulmonary Hypertension in HFpEF.pdf Management of Obesity – Drugs and Surgical Considerations.mp4 Management of Obesity – Drugs and Surgical Considerations.pdf Mechanisms limiting stroke volume reserve in patients with HFpEF- the potential role of interventricular dependence in the upright position.mp4 Microvascular Dysfunction in HFpEF.mp4 Microvascular Dysfunction in HFpEF.pdf MRAs and ARNIs – Trials, Tribulations, and Recommendations.mp4 MRAs and ARNIs – Trials, Tribulations, and Recommendations.pdf Overcoming the Sedentary Lifestyle – Exercise as Prevention and Treatment for HFpEF.mp4 Overcoming the Sedentary Lifestyle – Exercise as Prevention and Treatment for HFpEF.pdf Paracardial fat is related to adverse ventricular interdependence in heart failure with preserved ejection fraction.mp4 Recap of Day 1 and Intro to Day 2.mp4 Recap of Day 1 and Intro to Day 2.pdf Regulation Of Skeletal Muscle Blood Flow And Oxygen Utilization In Heart Failure With Preserved Ejection Fraction During Small Muscle Mass Exercise.mp4 SGLT2i- Outcomes and Controversies.mp4 SGLT2i- Outcomes and Controversies.pdf Sleep Apnea in HFpEF.pdf Splanchnic Nerve Modulation in HFpEF.mp4 Splanchnic Nerve Modulation in HFpEF.pdf To the Cath Lab – Manuevers and Challenges to Make the Diagnosis and When to Biopsy.mp4 To the Cath Lab – Manuevers and Challenges to Make the Diagnosis and When to Biopsy.pdf Update on Amyloid Therapies.mp4 Update on Amyloid Therapies.pdf Vasohibin Inhibition Improves Relaxation Kinetics in a Rodent Model of HFpEF.mp4 Wholebody macronutrient tracing in a mouse model of heart failure with preserved ejection fraction.mp4